Panagiotakos D B, Pitsavos C, Das U N, Skoumas Y, Stefanadis C
Department of Nutrition-Dietetics, Office of Biostatistics-Epidemiology, Harokopio University, Athens, Greece.
Diabetes Obes Metab. 2007 Sep;9(5):660-8. doi: 10.1111/j.1463-1326.2006.00640.x.
Individuals with the metabolic syndrome (MS) are at high risk for coronary heart disease. In this study, we evaluated the levels of inflammatory, lipidaemic and glycaemic control markers in subjects with and without MS, as given by different definitions.
During 2001-2002, we randomly enrolled 1,514 men (18-87 years old) and 1,528 women (18-89 years old), without any clinical evidence of cardiovascular disease, from the Attica area, Greece. Among several variables, we also measured inflammatory markers, total antioxidant capacity, glucose and insulin levels and various lipids. MS was defined according to either the National Cholesterol Education Program Adult Treatment Panel (NCEP ATP) III criteria or the International Diabetes Federation (IDF) Epidemiology Task Force group. In all the analyses, subjects with diabetes were excluded.
The prevalence of the MS was 17.9% according to the NCEP definition and 48.9% according to the IDF definition (p < 0.001). The prevalence of MS was higher in men compared with women according to both definitions (p for gender differences <0.001). Moreover, 3.9% of the total study sample fulfilled only the NCEP criteria, but not the IDF, while 38.6% fulfilled only the IDF criteria. Subjects who were defined as having MS using the IDF criteria were younger, had higher body mass index, C-reactive protein, fibrinogen, tumour necrosis factor-alpha levels, total antioxidant capacity and lower glucose and insulin levels.
Prevalence of the MS is very high among Greek adults when the IDF definition is used, while it is still considerable when we adopt the NCEP criteria. It is evident that subjects who fulfilled the IDF criteria showed increased levels of inflammatory markers compared with those who fulfilled the NCEP ATP III criteria.
患有代谢综合征(MS)的个体患冠心病的风险很高。在本研究中,我们评估了根据不同定义患有和未患有MS的受试者的炎症、血脂和血糖控制标志物水平。
在2001年至2002年期间,我们从希腊阿提卡地区随机招募了1514名男性(18 - 87岁)和1528名女性(18 - 89岁),这些人没有任何心血管疾病的临床证据。在多个变量中,我们还测量了炎症标志物、总抗氧化能力、血糖和胰岛素水平以及各种脂质。MS根据美国国家胆固醇教育计划成人治疗小组(NCEP ATP)III标准或国际糖尿病联盟(IDF)流行病学工作组的标准进行定义。在所有分析中,排除患有糖尿病的受试者。
根据NCEP定义,MS的患病率为17.9%,根据IDF定义为48.9%(p < 0.001)。根据这两种定义,男性中MS的患病率均高于女性(性别差异p < 0.001)。此外,总研究样本中有3.9%仅符合NCEP标准,而不符合IDF标准,而38.6%仅符合IDF标准。使用IDF标准定义为患有MS的受试者更年轻,体重指数、C反应蛋白、纤维蛋白原、肿瘤坏死因子-α水平、总抗氧化能力更高,血糖和胰岛素水平更低。
使用IDF定义时,希腊成年人中MS的患病率非常高,而采用NCEP标准时患病率仍然相当可观。显然,符合IDF标准的受试者与符合NCEP ATP III标准的受试者相比炎症标志物水平升高。